Navigation Links
Dynatronics to Release Second Quarter Results Friday, February 13, 2009; Conference Call set for 1:00 p.m. ET
Date:2/11/2009

SALT LAKE CITY, Feb. 11 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT) will release financial results for its quarter and six months ended December 31, 2008 during the morning of Friday, February 13, 2009.

Dynatronics has scheduled a conference call for investors later that day at 1:00 p.m. ET to discuss its results for the quarter and six month periods. Those interested in participating should call 800-839-9416 and use passcode: 9321818.

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets.


'/>"/>
SOURCE Dynatronics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. NASDAQ Gives Dynatronics a Second Three-Month Extension for Minimum Bid Price Compliance
2. Dynatronics Announces Changes to Board and Launches Operational Improvement Process
3. Dynatronics to Release First Quarter Results Friday, November 14, 2008; Conference Call Set for 1:30 p.m. ET
4. Dynatronics Announces Fiscal Year 2008 Operating Results
5. Dynatronics to Release Fourth Quarter and Year-end Results Monday, September 29, 2008; Conference Call Set for 3:00 p.m. ET
6. Dynatronics Elects Mark A. Crockett to its Board of Directors
7. Dynatronics Receives NASDAQ Minimum Bid Price Deficiency Letter
8. Dynatronics Acquisitions Boost Sales 80 Percent in Third Quarter
9. Dynatronics to Release Third Quarter Results Wednesday, May 14, 2008; Conference Call Set for 2:30 p.m. ET
10. Dynatronics Reduces Annual Expenses by $1.9 Million
11. Dynatronics Introduces New DynaPro Spinal Health System and X5 Turbo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... ... August 17, 2017 , ... An August 2 article ... obtaining plastic surgery, largely influenced by the growing popularity of “pretty boys” in both ... notes that standards of male appearance are changing not only in the Asian nation, ...
(Date:8/17/2017)... ... 2017 , ... Pot Valet is a leading provider of premium medical-grade cannabis ... state, and soon, every state in the country, the company offers patients safe, legal, ... altogether. , According to Pot Valet, all California patients have the legal ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... A recent ... to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. The FDA outlines ... Part 11 ruling. , Presented as part of the Beckman Coulter Life ...
(Date:8/16/2017)... Los Angeles, California (PRWEB) , ... August 16, 2017 , ... An August 3rd ... patients that was the subject of a report in JAMA (the Journal of the American ... (BMIs) above 50 were able to achieve BMIs under 30, when compared to patients with ...
(Date:8/16/2017)... ... August 16, 2017 , ... For the second ... England student to educate the public on the impact of concussions. Brooke Mills, ... first-ever National Concussion Awareness Day. , Brooke is working diligently is to raise ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... quarter ended June 30, 2017, and updated its financial ... For the fiscal third quarter, Hill-Rom reported ... per diluted share in the prior-year period. These results ... per diluted share primarily related to the non-cash write-down ...
(Date:7/27/2017)... Pharmaceutical Services, Inc. (NYSE: WST ) today ... updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a record ... at constant currency (organic) grew by 3.9%. ... $0.60 in the prior-year quarter. Second-quarter 2017 adjusted diluted ...
(Date:7/26/2017)... July 26, 2017 Sancilio Pharmaceuticals Company, Inc. ... clinical trial evaluating Altemia TM , an oral therapy ... Sickle Cell Disease (SCD). The SCOT Trial, is a ... and safety of Altemia TM in pediatric patients ... US IND 125274. ...
Breaking Medicine Technology: